InspireMD

InspireMD is a forward-thinking medical device company committed to developing and delivering innovative solutions in the neurovascular space. With a focus on stroke prevention, InspireMD offers proprietary stent designs integrated with embolic prevention systems (EPS). These systems are engineered to provide unparalleled neurovascular protection.

InspireMD's dedication to technological advancement is evident in its proprietary MicroNet™ technology. The company strives to establish its products as the gold standard in treating carotid artery disease. By delivering exceptional acute results and ensuring durable, stroke-free long-term outcomes, InspireMD is revolutionizing patient care through its flagship CGuard™ EPS stent platform.

InspireMD's CGuard™ platform features the patented MicroNet™ mesh technology, uniquely designed to minimize the risk of stroke during and after Carotid Artery Stenting (CAS). InspireMD (NSPR) is publicly traded on the NASDAQ Capital Market, reflecting its commitment to growth and innovation in the medical device industry. We invite the management team at InspireMD to create a customized and exclusive company showcase and product listing on our platform.